Acute respiratory syncytial virus was associated with elevated incidence of cardiovascular events among older adults, ...

Knowledge of respiratory syncytial virus (RSV) disease and RSV vaccine eligibility is low among hospitalized older adults, ...

The Ministry of Public Health (MoPH) has advised the public, especially the vulnerable to take the Respiratory Syncytial Virus (RSV) ...

By Blake Brittain (Reuters) -British pharmaceutical giant GlaxoSmithKline and rival Pfizer have agreed to end a lawsuit that ...

The authors assessed the patient characteristics associated with RSV vaccination among older adults hospitalized during the ...

As the respiratory syncytial virus (RSV) vaccine field grapples with a significantly reduced market size thanks to regulatory ...

(NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for virology and immunology ...

Children aged 6 months to 12 years are the main spreaders of respiratory syncytial virus (RSV) infections within their ...

Coronavirus and respiratory syncytial virus (RSV) are two kinds of respiratory viruses that can infect you and have similar symptoms. It can be hard to tell the difference between infections ...

Older adults and people with certain medical conditions are more likely to receive the respiratory syncytial virus (RSV) ...

The European Commission approved Pfizer's respiratory syncytial virus vaccine for the prevention of lower respiratory tract ...

GSK Plc and Pfizer Inc. settled a patent-infringement lawsuit over competing vaccines for RSV, ending the dispute in Delaware ...